Theranim develops a software‑as‑a‑medical‑device (SaMD) that uses generative AI to create avatar‑driven, interactive digital animations for precision psychiatry.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional psychiatric assessments rely on static questionnaires and clinician-led interviews, which can be time‑consuming, subject to bias, and difficult to scale for remote or high‑volume care.
Solution
Theranim offers a software‑as‑a‑medical‑device that leverages generative AI to produce avatar‑driven, interactive digital animations for precision psychiatry. The platform presents patients with personalized, real‑time digital interactions that are aligned with DSM‑5 criteria, enabling more objective and scalable assessments. Clinicians receive structured behavioral data and AI‑derived insights that support diagnostic decisions and treatment planning. The cloud‑based solution can be accessed remotely, facilitating consistent evaluation across diverse care settings while maintaining regulatory compliance.
Target Audience
Primary customers are psychiatrists, mental health clinics, and telepsychiatry providers seeking scalable, data‑driven assessment tools.
Features
- Generative AI creates patient‑specific avatars that conduct interactive, scenario‑based assessments
- Real‑time digital animation captures verbal and non‑verbal responses for objective data collection
- Built‑in DSM‑5 compliance ensures alignment with established psychiatric diagnostic standards
- AI analytics provide structured symptom scores and risk indicators to assist clinicians
- Secure, cloud‑hosted platform supports remote deployment and integration with existing electronic health record systems
- Scalable architecture allows simultaneous assessments for multiple patients without additional hardware